Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Dopamine release via the vacuolar ATPase V0 sector c-subunit, confirmed in N18 neuroblastoma cells, results in behavioral recovery in hemiparkinsonian mice.

Jin D, Muramatsu S, Shimizu N, Yokoyama S, Hirai H, Yamada K, Liu HX, Higashida C, Hashii M, Higashida A, Asano M, Ohkuma S, Higashida H.

Neurochem Int. 2012 Nov;61(6):907-12. doi: 10.1016/j.neuint.2011.12.021. Epub 2012 Jan 14.

PMID:
22265874
[PubMed - indexed for MEDLINE]
2.

Chromosomal localization of three vacuolar-H+ -ATPase 16 kDa subunit (ATP6V0C) genes in the murine genome.

Simckes AM, Swanson SK, White RA.

Cytogenet Genome Res. 2002;97(1-2):111-5.

PMID:
12438748
[PubMed - indexed for MEDLINE]
3.

Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymes.

Muramatsu S, Fujimoto K, Ikeguchi K, Shizuma N, Kawasaki K, Ono F, Shen Y, Wang L, Mizukami H, Kume A, Matsumura M, Nagatsu I, Urano F, Ichinose H, Nagatsu T, Terao K, Nakano I, Ozawa K.

Hum Gene Ther. 2002 Feb 10;13(3):345-54.

PMID:
11860702
[PubMed - indexed for MEDLINE]
4.

Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.

Shen Y, Muramatsu SI, Ikeguchi K, Fujimoto KI, Fan DS, Ogawa M, Mizukami H, Urabe M, Kume A, Nagatsu I, Urano F, Suzuki T, Ichinose H, Nagatsu T, Monahan J, Nakano I, Ozawa K.

Hum Gene Ther. 2000 Jul 20;11(11):1509-19.

PMID:
10945765
[PubMed - indexed for MEDLINE]
5.

Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease.

Wachtel SR, Bencsics C, Kang UJ.

J Neurochem. 1997 Nov;69(5):2055-63.

PMID:
9349551
[PubMed - indexed for MEDLINE]
6.
7.

Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

Mandel RJ, Rendahl KG, Spratt SK, Snyder RO, Cohen LK, Leff SE.

J Neurosci. 1998 Jun 1;18(11):4271-84.

PMID:
9592104
[PubMed - indexed for MEDLINE]
Free Article
8.

rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease.

Manfredsson FP, Burger C, Sullivan LF, Muzyczka N, Lewin AS, Mandel RJ.

Exp Neurol. 2007 Oct;207(2):289-301. Epub 2007 Jul 10.

PMID:
17678648
[PubMed - indexed for MEDLINE]
9.

alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.

Bazzu G, Calia G, Puggioni G, Spissu Y, Rocchitta G, Debetto P, Grigoletto J, Zusso M, Migheli R, Serra PA, Desole MS, Miele E.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):482-90. Review.

PMID:
20522009
[PubMed - indexed for MEDLINE]
10.

Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.

Robinson TE, Noordhoorn M, Chan EM, Mocsary Z, Camp DM, Whishaw IQ.

Synapse. 1994 May;17(1):16-25.

PMID:
8042143
[PubMed - indexed for MEDLINE]
11.

Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.

Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K, Hoka S, Saji M.

Neurosci Res. 2005 Mar;51(3):299-308. Epub 2005 Jan 8.

PMID:
15710494
[PubMed - indexed for MEDLINE]
12.

In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.

Hoffman AF, van Horne CG, Eken S, Hoffer BJ, Gerhardt GA.

Exp Neurol. 1997 Sep;147(1):130-41.

PMID:
9294410
[PubMed - indexed for MEDLINE]
13.

Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.

Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC.

Gene Ther. 1999 Dec;6(12):1936-51.

PMID:
10637445
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.

Moore AE, Cicchetti F, Hennen J, Isacson O.

Exp Neurol. 2001 Dec;172(2):363-76.

PMID:
11716560
[PubMed - indexed for MEDLINE]
17.

Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.

Snyder GL, Keller RW Jr, Zigmond MJ.

J Pharmacol Exp Ther. 1990 May;253(2):867-76.

PMID:
2110978
[PubMed - indexed for MEDLINE]
18.

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC.

Exp Neurol. 1998 Dec;154(2):261-75.

PMID:
9878166
[PubMed - indexed for MEDLINE]
19.

Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.

Eslamboli A, Georgievska B, Ridley RM, Baker HF, Muzyczka N, Burger C, Mandel RJ, Annett L, Kirik D.

J Neurosci. 2005 Jan 26;25(4):769-77.

PMID:
15673656
[PubMed - indexed for MEDLINE]
Free Article
20.

Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.

Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.

Brain Res Rev. 2006 Sep;52(2):244-56. Epub 2006 Apr 27. Review.

PMID:
16644019
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk